Articles On Adherium (ASX:ADR)

Digital health company Adherium(ASX:ADR) has appointed Dr Peter Stratford as its CEO and Mike Motion at its Chief Commercial Officer.

HeraMED’s (ASX:HMD) foetal ultrasound heart rate monitor has got its long awaited green light to enter the US market and it has doubled in just a few days. The US Food and Drug Administration has approved its 510(k) application meaning it c...

Here’s our fortnightly wrap of the major small cap health stock winners and losers. For the second fortnight in a row, Novita Healthcare (ASX:NHL) is the best-performing ASX small cap healthcare stock, up 72 per cent to 7.8c. Novita was the...

At the close of trading session on 24th October 2019, the benchmark index, i.e. S&P/ ASX 200 closed at 6,693.6 points with a rise of 20.5 points. Designing a portfolio for the purpose of making investment requires a meticulous approach....

On Stockhead today: Aussie small caps trying to tackle the opioid crisis, which car manufacturers will survive the EV revolution, Barry FitzGerald looks at upcoming juniors, and how South Australian small caps are putting themselves back on...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Australian respiratory medical device company Adherium (ASX:ADR) has announced a new strategic data-based initiative with Summatix.

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel...

Adherium (ASX: ADR) shares have risen 19 per cent this morning following news the asthma monitoring firm had received clearance to sell its devices in the US. The Food and Drug Administration (FDA) granted 510(k) clearance for its Hailie se...